Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.

Men and women experience skin aging differently due to changes in sex hormone levels with age.

The document concludes that computational methods using networks and various data can improve the process of finding new uses for existing drugs.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Hormonal therapies are effective for managing hair and skin symptoms in women with PCOS.

The birth control combination of ethinylestradiol and drospirenone helps treat symptoms of polycystic ovary syndrome.

Androgen treatment with dihydrotestosterone may help maintain height in patients with 5-α-reductase type 2 deficiency, especially before puberty.

Testosterone may influence COVID-19 severity and outcomes.

Birth control pills increase the risk of blood clots, especially within the first year and with certain types.

Testosterone replacement therapy should be used for men with low testosterone levels and symptoms of hypogonadism, after careful diagnosis and considering individual needs.

Insulin resistance linked to obesity may increase COVID-19 severity.

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.

The conclusion is that there is a high demand for new contraceptives that provide both pregnancy prevention and protection against STIs, along with additional health benefits.

Urologic diseases and treatments in older men can negatively affect fertility, and doctors should talk to patients about this.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Early diagnosis and individualized treatment improve outcomes for Congenital Adrenal Hyperplasia.

New treatments for male hypogonadism are effective and should be personalized.

Sabal and Urtica extract works as well as finasteride for treating BPH, with fewer side effects.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

The current system can't fully test all combination treatments, so alternative methods and regulatory flexibility are needed.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Testosterone therapy and surgeries like mastectomy improve transgender men's lives and mental health with low risks and high satisfaction.

Dermatologists should screen for and manage psychological issues in patients with skin conditions to improve their quality of life.

Finasteride may increase erectile dysfunction risk in patients with benign prostatic hyperplasia.

Adrenal gland disease is common in ferrets and causes hair loss and other symptoms.

Testosterone significantly affects sexual desire in both men and women, but its impact on women is more complex and influenced by psychological factors.

Environmental factors like diet and vitamin levels, especially Vitamin D, can affect autoimmune diseases differently, with lifestyle changes potentially improving outcomes.

Traditional Chinese Medicine and acupuncture may improve Polycystic Ovarian Syndrome symptoms and reduce costs, but more research is needed.

The drugs finasteride and dutasteride reduce low-grade prostate cancers but may double the risk of high-grade cancers.